Fungisiso yeStock yeExelixis (EXEL)
AI forecast: EXEL
AI inoburitsa mutengo wechinangwa wezuva rinotevera rekutengesa, mugumo wevhiki uye mugumo wemwedzi. Shanduko inoyerwa kubva pamutengo wekupedzisira. Izvi zvinongova zvifungisiso zvehutano, hazviri mazano ekudyara.
Price over the last 6 months
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Nzira yekufungisisa
Nzira yekufungisisa — yese fungisiso yekare pamwe chete nekukwira kwazvino — ndiyo Premium.
Unlock PremiumNdiyi ya Kompani Iyi
Exelixis, Inc. is a biotechnology company specializing in the development of promising small-molecule drugs for the treatment of cancer and other serious diseases, including kidney disease, thyroid cancer, and advanced melanoma. The company also establishes strategic partnerships with other pharmaceutical and biotechnology firms.